The purpose of this study is to determine whether pharmacologic lowering of low density lipoprotein cholesterol (LDL), initiated in healthy young to middle aged adults can eliminate or markedly reduce the composite endpoint of incident all cause mortality, myocardial infarction, stroke or coronary revascularization.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
28
20 mg of atorvastatin daily
Dr. Killian De Blacam Family Medical Practice
Greater Sudbury, Ontario, Canada
Dr. Gregory Garrioch Family Medical Practice
Greater Sudbury, Ontario, Canada
Dr. Reena Dhatt
Greater Sudbury, Ontario, Canada
Time to first occurrence of myocardial infarction, revascularization, stroke or death from any cause in the follow up period
Time frame: Up to 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.